Intravenous Equipment Market Valued at US$ 12.3 Billion, Expected to Reach US$ 16.1 Billion by 2027

The current valuation of the intravenous equipment market stands at US$ 12.3 billion, with a projected compound annual growth rate (CAGR) of 5.6%. It is anticipated to reach US$ 16.1 billion by 2027. This market plays a vital role in the global healthcare sector, offering essential tools and devices for the direct administration of fluids, medications, and nutrients into a patient's bloodstream. Intravenous therapy has emerged as a fundamental aspect of modern medicine, providing a rapid and efficient method for drug delivery and fluid replacement, particularly in emergencies and for individuals with chronic illnesses. The consistent growth of the intravenous equipment market can be attributed to factors such as the rising prevalence of chronic diseases, the aging population, and ongoing advancements in medical technology.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7710

Market Opportunity:

The intravenous equipment market is poised for substantial growth, driven by various factors. The increasing prevalence of chronic diseases like diabetes, cancer, and cardiovascular conditions has significantly boosted the demand for intravenous therapies. Additionally, a growing recognition of the effectiveness of IV treatments has led to a rising trend in home-based intravenous therapies, creating a promising niche market. The continuous development of innovative and user-friendly IV equipment, including smart pumps and wearable infusion devices, opens up further avenues for growth by enhancing patient convenience and improving treatment outcomes.

Beyond the traditional healthcare setting, the COVID-19 pandemic has highlighted the crucial role of intravenous equipment. The rapid worldwide development and deployment of vaccines have necessitated a robust infrastructure for intravenous administration, further accentuating the market's importance. Moreover, intravenous equipment plays a pivotal role in managing critically ill patients in intensive care units, emergency departments, and during surgeries, offering lucrative opportunities for market expansion.

Market Challenges:

The intravenous equipment market confronts various challenges, with one significant issue being the elevated cost associated with certain types of IV equipment, particularly advanced infusion pumps and accessories. This financial burden can strain healthcare budgets, potentially restricting access to life-saving therapies in specific regions. Additionally, there is a growing concern regarding medical errors in IV therapy, encompassing dosing inaccuracies and infection risks. Addressing these concerns necessitates stringent regulations and quality control measures to ensure patient safety.

Furthermore, the market is characterized by intense competition among key players, driving an ongoing demand for innovation and product differentiation. The continuous evolution of technology and the imperative for compatibility with electronic health records require substantial investments in research and development, creating a potential barrier to entry for smaller companies. Additionally, the increasing preference for non-invasive drug delivery systems, such as oral medications or transdermal patches, poses a challenge to the growth of the intravenous equipment market.

Key Players:

Becton, Dickinson and Company
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
Baxter International Inc.
Smiths Medical
ICU Medical, Inc.
C. R. Bard, Inc.
Terumo Corporation
Moog, Inc.
AngioDynamics, Inc.

Competitive Landscape:

BD (Becton, Dickinson and Company) has recently acquired Cytognos, a privately-owned company based in Salamanca, Spain, that specializes in flow cytometry technologies for the diagnosis of blood cancer, detection of minimal residual disease, and immune monitoring study for blood disorders.

Intravenous Equipment Industry Research Segmentation

By Product :
IV Catheters
Securement Devices
Administration Sets
Infusion Sets
Drip Chambers
Others

End User :
Hospitals
Clinics
Ambulatory Care Centers
Others

By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7710

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.